Almirall, S.A. (ALM) a global pharmaceutical company dedicated to medical dermatology announced today that China’s National Medical Products Administration (NMPA) has approved Seysara® (sarecycline ...

HONG KONG, Jan. 29, 2026 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announced positive topline results from the Phase III open-label study ( NCT06248008) evaluating ...

Among nearly 20 different agents and treatment combinations, topical triple-agent fixed-dose combination (FDC) gel emerged as the most efficacious for moderate-to-severe acne. Researchers who ...

Please provide your email address to receive an email when new articles are posted on . Topical triple-agent fixed-dose combination had the best log-ratio for treatment success. It also proved to be ...

USA: Researchers have found in a new study that Clindamycin phosphate 1.2% / adapalene 0.15% / benzoyl peroxide 3.1% (CAB) ...

--The Phase III clinical trial of ASC40 for moderate to severe acne vulgaris will enroll 480 subjects --The protocol of Phase III clinical trial has been agreed by Center for Drug Evaluation, National ...

Please provide your email address to receive an email when new articles are posted on . Denifanstat, a fatty acid synthase inhibitor, was effective in the treatment of moderate to severe acne vulgaris ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Picture this: You just got out of bed after a long night’s rest and you’re feeling super refreshed and ...

Previous associations between depression, suicidal behavior and the acne drug isotretinoin may be explained by presence of the acne itself, rather than treatment with the medication, according to ...

Acne triggered by testosterone therapy varies from person to person. That means there isn’t a universal answer to how long it lasts. Here’s what we know and some treatment tips, like home remedies, ...